Metallothionein 2 pseudogene 1 (MT2P1)

Metallothionein 2 pseudogene 1 (MT2P1) is a processed pseudogene related to the metallothionein gene family, particularly the functional metallothionein 2 (MT2A) protein-coding gene[2][5][7]. Pseudogenes like MT2P1 arise via duplication or retrotransposition events and accumulate mutations that prevent them from producing functional proteins[3][7]. MT2P1 lacks coding potential due to such disabling mutations and is not known to be transcribed into a functional product, nor is it recognized as a therapeutic target or implicated directly in human disease[2][3][5][7]. Reports in the literature frequently differentiate functional metallothionein isoforms (such as MT1, MT2A, MT3, and MT4) from their pseudogene relatives[3][2][5][7]. Therefore, MT2P1 is not a therapeutic or pharmacological target and is typically excluded from studies focused on MT function or disease involvement. Key Notes: - Metallothionein 2 (MT2A) is a functional gene critical for heavy metal homeostasis and protection against oxidative stress, but MT2P1 is a non-coding pseudogene[2][3][7]. - “Pseudogene” status means it cannot be targeted therapeutically, does not have biological function, and is not involved in drug interactions or disease modulation[2][5][7]. - Its listing as a target is incorrect; it is most relevant for genomics or evolutionary studies rather than therapeutic research[2][3][7].

Other names

Metallothionein II pseudogene 1MT-II pseudogene 1processed metallothionein 2 pseudogene